Professor Paul Kellam Elected Fellow of the Academy of Medical Sciences

RQ Biotechnology is proud to announce that Professor Paul Kellam has been elected a Fellow of the Academy of Medical Sciences, one of the UK’s highest honours in biomedical and health research.

Fellows are elected for excellence in biomedical and health research, scientific leadership and contributions to the wider scientific community.

Professor Kellam is internationally recognised for his pioneering work in virology, infectious disease biology and translational science.

Over a distinguished career spanning academia
and biotechnology, he has helped shape global understanding of viral genetics and emerging infectious diseases, with research contributions spanning HIV, influenza, Ebola, MERS and COVID-19. His work has directly informed antiviral strategies, pandemic preparedness and the development of novel therapeutic approaches.

At RQ Biotechnology, Professor Kellam contributes his extensive expertise in virology and translational science to support the company’s mission of developing innovative antibody therapeutics against virus diseases.

Commenting on the announcement, Mike Westby, Chief Executive Officer of RQ Biotechnology, said:

“Paul’s election to the Academy of Medical Sciences is a tremendous and well-deserved recognition of his exceptional scientific achievements and leadership in infectious disease research. His work has fundamentally advanced our understanding of viral pathogens and pandemic preparedness, while continuing to shape innovation across academia, public health, and biotechnology. We are incredibly fortunate to have Paul’s expertise and vision helping guide RQ Biotechnology.”

Professor Kellam said:

“It is an honour to be elected a Fellow of the Academy of Medical Sciences. I have been extraordinarily fortunate to work alongside brilliant colleagues, students and partners across academia, healthcare and industry throughout my career. When these are combined, biotech companies like RQ Bio can form and thrive. I look forward to working with colleagues in the Academy to advance further the priorities of supporting biopharmaceutical science to improve the lives of patients and strengthen UK global competitiveness”.

The Academy of Medical Sciences brings together exceptional researchers across the biomedical and health sciences to advance research, influence policy and improve health outcomes worldwide. Fellowship is awarded through a rigorous peer-review process recognising individuals who have made outstanding contributions to medical science